| 9.2 |
55.3 |
GO:0010624 |
regulation of Schwann cell proliferation(GO:0010624) |
| 9.0 |
27.1 |
GO:0014012 |
peripheral nervous system axon regeneration(GO:0014012) |
| 7.3 |
21.8 |
GO:0019343 |
cysteine biosynthetic process via cystathionine(GO:0019343) cysteine biosynthetic process(GO:0019344) |
| 7.2 |
21.7 |
GO:1902460 |
regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
| 6.5 |
38.8 |
GO:0060718 |
chorionic trophoblast cell differentiation(GO:0060718) |
| 5.9 |
29.3 |
GO:2000255 |
negative regulation of male germ cell proliferation(GO:2000255) |
| 5.4 |
16.3 |
GO:1904706 |
negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
| 5.3 |
10.6 |
GO:0072197 |
ureter morphogenesis(GO:0072197) |
| 5.2 |
26.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 5.1 |
15.4 |
GO:0044333 |
Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
| 4.4 |
21.8 |
GO:0051045 |
negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 4.0 |
12.0 |
GO:0014809 |
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 3.8 |
37.9 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 3.6 |
10.8 |
GO:0003195 |
tricuspid valve development(GO:0003175) tricuspid valve morphogenesis(GO:0003186) tricuspid valve formation(GO:0003195) right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 3.4 |
10.3 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 3.4 |
10.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 3.3 |
23.2 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 3.3 |
32.9 |
GO:0015721 |
bile acid and bile salt transport(GO:0015721) |
| 3.2 |
16.1 |
GO:1900085 |
negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) |
| 3.2 |
9.6 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 3.1 |
9.2 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 2.9 |
11.5 |
GO:2001016 |
positive regulation of skeletal muscle cell differentiation(GO:2001016) |
| 2.9 |
17.3 |
GO:1902847 |
macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) |
| 2.8 |
11.3 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 2.8 |
11.2 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 2.7 |
8.1 |
GO:0038095 |
positive regulation of mast cell cytokine production(GO:0032765) Fc-epsilon receptor signaling pathway(GO:0038095) |
| 2.7 |
8.1 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) regulation of nucleoside transport(GO:0032242) negative regulation of circadian sleep/wake cycle, non-REM sleep(GO:0042323) negative regulation of mucus secretion(GO:0070256) |
| 2.5 |
12.3 |
GO:0034372 |
very-low-density lipoprotein particle remodeling(GO:0034372) |
| 2.4 |
7.2 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 2.4 |
16.8 |
GO:0051611 |
negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 2.4 |
7.2 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 2.3 |
7.0 |
GO:0019401 |
alditol biosynthetic process(GO:0019401) |
| 2.3 |
9.1 |
GO:1903966 |
monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
| 2.2 |
13.0 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 2.2 |
6.5 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 2.0 |
11.8 |
GO:0019532 |
oxalate transport(GO:0019532) |
| 1.9 |
19.1 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 1.9 |
5.7 |
GO:1903054 |
negative regulation of extracellular matrix organization(GO:1903054) |
| 1.8 |
8.8 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 1.7 |
3.4 |
GO:0035622 |
intrahepatic bile duct development(GO:0035622) |
| 1.7 |
5.1 |
GO:0035964 |
COPI-coated vesicle budding(GO:0035964) |
| 1.7 |
8.3 |
GO:1903726 |
negative regulation of phospholipid metabolic process(GO:1903726) |
| 1.7 |
5.0 |
GO:0001869 |
regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.6 |
6.6 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 1.6 |
4.8 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 1.6 |
7.8 |
GO:0051365 |
cellular response to potassium ion starvation(GO:0051365) |
| 1.5 |
12.3 |
GO:1901387 |
positive regulation of voltage-gated calcium channel activity(GO:1901387) |
| 1.5 |
3.1 |
GO:0035990 |
tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 1.5 |
6.1 |
GO:1903237 |
negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 1.5 |
4.5 |
GO:1902524 |
negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
| 1.5 |
6.0 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 1.5 |
12.0 |
GO:0035542 |
regulation of SNARE complex assembly(GO:0035542) |
| 1.5 |
1.5 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 1.5 |
5.9 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.5 |
2.9 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) |
| 1.4 |
8.6 |
GO:0043415 |
positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
| 1.4 |
4.1 |
GO:0021529 |
spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
| 1.3 |
5.3 |
GO:1903181 |
regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) |
| 1.3 |
4.0 |
GO:0003357 |
noradrenergic neuron differentiation(GO:0003357) |
| 1.2 |
3.7 |
GO:2000501 |
natural killer cell chemotaxis(GO:0035747) regulation of natural killer cell chemotaxis(GO:2000501) |
| 1.2 |
4.9 |
GO:0071449 |
cellular response to lipid hydroperoxide(GO:0071449) |
| 1.2 |
6.1 |
GO:1900170 |
negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 1.2 |
6.1 |
GO:1904721 |
regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
| 1.2 |
10.8 |
GO:0061088 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 1.2 |
4.8 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 1.2 |
3.5 |
GO:0072092 |
ureteric bud invasion(GO:0072092) |
| 1.1 |
4.6 |
GO:0006668 |
sphinganine-1-phosphate metabolic process(GO:0006668) |
| 1.1 |
16.8 |
GO:0035994 |
response to muscle stretch(GO:0035994) |
| 1.1 |
12.2 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 1.1 |
3.3 |
GO:1905154 |
negative regulation of tumor necrosis factor secretion(GO:1904468) negative regulation of membrane invagination(GO:1905154) |
| 1.1 |
11.0 |
GO:0035584 |
calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 1.1 |
3.2 |
GO:1904339 |
negative regulation of dopaminergic neuron differentiation(GO:1904339) |
| 1.1 |
3.2 |
GO:0008228 |
opsonization(GO:0008228) modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 1.1 |
14.8 |
GO:0072010 |
renal filtration cell differentiation(GO:0061318) glomerular epithelium development(GO:0072010) glomerular visceral epithelial cell differentiation(GO:0072112) glomerular epithelial cell differentiation(GO:0072311) |
| 1.0 |
4.0 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 1.0 |
3.9 |
GO:1901475 |
pyruvate transmembrane transport(GO:1901475) |
| 0.9 |
4.7 |
GO:0014829 |
vascular smooth muscle contraction(GO:0014829) |
| 0.9 |
3.8 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.9 |
11.2 |
GO:0070995 |
NADPH oxidation(GO:0070995) |
| 0.9 |
2.8 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.9 |
14.8 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.9 |
9.2 |
GO:0070886 |
positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.9 |
3.7 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.9 |
7.3 |
GO:0048681 |
negative regulation of axon regeneration(GO:0048681) |
| 0.9 |
9.1 |
GO:0060136 |
embryonic process involved in female pregnancy(GO:0060136) |
| 0.9 |
4.5 |
GO:0032911 |
nerve growth factor production(GO:0032902) negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 0.9 |
2.6 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.8 |
3.4 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.8 |
2.5 |
GO:0061537 |
glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
| 0.8 |
3.2 |
GO:0000255 |
allantoin metabolic process(GO:0000255) |
| 0.8 |
2.4 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.8 |
2.4 |
GO:1904049 |
regulation of spontaneous neurotransmitter secretion(GO:1904048) negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
| 0.8 |
5.4 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.8 |
7.7 |
GO:1901841 |
regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.8 |
4.6 |
GO:0010528 |
regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
| 0.8 |
21.9 |
GO:0010866 |
regulation of triglyceride biosynthetic process(GO:0010866) |
| 0.7 |
5.0 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.7 |
5.7 |
GO:0033564 |
anterior/posterior axon guidance(GO:0033564) |
| 0.7 |
11.3 |
GO:0034142 |
toll-like receptor 4 signaling pathway(GO:0034142) |
| 0.7 |
7.0 |
GO:0043206 |
extracellular fibril organization(GO:0043206) |
| 0.7 |
3.4 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.7 |
11.4 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.7 |
3.4 |
GO:0045006 |
DNA deamination(GO:0045006) |
| 0.7 |
0.7 |
GO:0021593 |
rhombomere morphogenesis(GO:0021593) |
| 0.7 |
2.7 |
GO:0050862 |
positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.7 |
2.0 |
GO:0050975 |
sensory perception of touch(GO:0050975) |
| 0.7 |
3.3 |
GO:0010025 |
wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
| 0.6 |
14.8 |
GO:0051894 |
positive regulation of focal adhesion assembly(GO:0051894) |
| 0.6 |
3.2 |
GO:2001286 |
regulation of caveolin-mediated endocytosis(GO:2001286) |
| 0.6 |
10.5 |
GO:0060134 |
prepulse inhibition(GO:0060134) |
| 0.6 |
3.7 |
GO:0060267 |
positive regulation of respiratory burst(GO:0060267) |
| 0.6 |
4.8 |
GO:0046415 |
urate metabolic process(GO:0046415) |
| 0.6 |
6.0 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.6 |
5.9 |
GO:0060294 |
cilium movement involved in cell motility(GO:0060294) |
| 0.6 |
2.9 |
GO:0070447 |
positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
| 0.6 |
2.3 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.6 |
1.1 |
GO:0002578 |
negative regulation of antigen processing and presentation(GO:0002578) |
| 0.6 |
4.6 |
GO:2000192 |
regulation of plasma membrane long-chain fatty acid transport(GO:0010746) negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of fatty acid transport(GO:2000192) |
| 0.6 |
1.7 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.6 |
1.7 |
GO:0060392 |
negative regulation of SMAD protein import into nucleus(GO:0060392) endothelial cell-cell adhesion(GO:0071603) |
| 0.6 |
6.7 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.6 |
3.3 |
GO:0006172 |
ADP biosynthetic process(GO:0006172) |
| 0.5 |
3.8 |
GO:0042095 |
interferon-gamma biosynthetic process(GO:0042095) |
| 0.5 |
1.6 |
GO:1903351 |
response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
| 0.5 |
1.6 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.5 |
7.3 |
GO:0021542 |
dentate gyrus development(GO:0021542) |
| 0.5 |
1.0 |
GO:2000338 |
chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
| 0.5 |
2.0 |
GO:0045896 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) |
| 0.5 |
0.5 |
GO:0038163 |
thrombopoietin-mediated signaling pathway(GO:0038163) |
| 0.5 |
2.4 |
GO:0032346 |
positive regulation of aldosterone metabolic process(GO:0032346) positive regulation of aldosterone biosynthetic process(GO:0032349) |
| 0.5 |
1.5 |
GO:0042138 |
meiotic DNA double-strand break formation(GO:0042138) |
| 0.5 |
2.4 |
GO:0007386 |
compartment pattern specification(GO:0007386) |
| 0.5 |
3.8 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.5 |
0.9 |
GO:0046888 |
negative regulation of hormone secretion(GO:0046888) |
| 0.5 |
3.3 |
GO:0032534 |
regulation of microvillus assembly(GO:0032534) |
| 0.5 |
0.9 |
GO:0050912 |
detection of chemical stimulus involved in sensory perception(GO:0050907) detection of chemical stimulus involved in sensory perception of taste(GO:0050912) |
| 0.5 |
2.3 |
GO:0030240 |
skeletal muscle thin filament assembly(GO:0030240) |
| 0.5 |
1.4 |
GO:0036118 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.5 |
2.3 |
GO:0050857 |
positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.5 |
0.9 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.5 |
3.2 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.4 |
5.8 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.4 |
3.1 |
GO:1904217 |
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.4 |
5.3 |
GO:0000054 |
ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.4 |
2.6 |
GO:0006123 |
mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.4 |
1.7 |
GO:0010756 |
positive regulation of plasminogen activation(GO:0010756) |
| 0.4 |
1.3 |
GO:0003032 |
detection of oxygen(GO:0003032) |
| 0.4 |
1.3 |
GO:0072531 |
pyrimidine-containing compound transmembrane transport(GO:0072531) |
| 0.4 |
14.8 |
GO:0090004 |
positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
| 0.4 |
1.7 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.4 |
4.5 |
GO:0019243 |
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
| 0.4 |
4.5 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.4 |
4.1 |
GO:0090385 |
phagosome-lysosome fusion(GO:0090385) |
| 0.4 |
0.4 |
GO:2000813 |
negative regulation of barbed-end actin filament capping(GO:2000813) |
| 0.4 |
9.3 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.4 |
2.4 |
GO:0000050 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.4 |
1.2 |
GO:0051204 |
protein insertion into mitochondrial membrane(GO:0051204) |
| 0.4 |
16.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.4 |
1.6 |
GO:0090315 |
negative regulation of protein targeting to membrane(GO:0090315) |
| 0.4 |
1.6 |
GO:1990743 |
protein sialylation(GO:1990743) |
| 0.4 |
6.6 |
GO:0002495 |
antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.4 |
1.6 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.4 |
1.1 |
GO:2001206 |
positive regulation of osteoclast development(GO:2001206) |
| 0.4 |
0.4 |
GO:0007521 |
muscle cell fate determination(GO:0007521) |
| 0.4 |
8.3 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.4 |
1.9 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.4 |
3.0 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.4 |
3.4 |
GO:0061299 |
retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.4 |
2.6 |
GO:0097421 |
liver regeneration(GO:0097421) |
| 0.4 |
0.7 |
GO:0048859 |
formation of anatomical boundary(GO:0048859) |
| 0.4 |
2.2 |
GO:0061087 |
positive regulation of histone H3-K27 methylation(GO:0061087) |
| 0.4 |
1.8 |
GO:0042699 |
follicle-stimulating hormone signaling pathway(GO:0042699) |
| 0.4 |
1.8 |
GO:0031547 |
brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 0.4 |
3.9 |
GO:2000465 |
regulation of glycogen (starch) synthase activity(GO:2000465) |
| 0.4 |
2.5 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.4 |
2.1 |
GO:1900028 |
negative regulation of ruffle assembly(GO:1900028) |
| 0.4 |
14.4 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.3 |
1.4 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.3 |
8.3 |
GO:0046039 |
GTP metabolic process(GO:0046039) |
| 0.3 |
3.1 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.3 |
2.7 |
GO:0090051 |
negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) |
| 0.3 |
4.4 |
GO:0021902 |
commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.3 |
1.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.3 |
4.4 |
GO:0043011 |
myeloid dendritic cell differentiation(GO:0043011) |
| 0.3 |
1.0 |
GO:0002043 |
blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.3 |
1.3 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
2.9 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.3 |
1.9 |
GO:0006570 |
tyrosine metabolic process(GO:0006570) |
| 0.3 |
1.0 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.3 |
1.9 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.3 |
0.9 |
GO:1903546 |
receptor localization to nonmotile primary cilium(GO:0097500) protein localization to photoreceptor outer segment(GO:1903546) |
| 0.3 |
0.9 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.3 |
2.1 |
GO:0045200 |
establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
| 0.3 |
43.2 |
GO:0031032 |
actomyosin structure organization(GO:0031032) |
| 0.3 |
3.6 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.3 |
4.5 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.3 |
2.9 |
GO:2001275 |
positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
| 0.3 |
2.9 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.3 |
1.1 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 |
5.1 |
GO:0010043 |
response to zinc ion(GO:0010043) |
| 0.3 |
0.9 |
GO:2000344 |
positive regulation of acrosome reaction(GO:2000344) |
| 0.3 |
0.3 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.3 |
7.2 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.3 |
1.4 |
GO:2000574 |
regulation of microtubule motor activity(GO:2000574) |
| 0.3 |
4.1 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.3 |
0.8 |
GO:0035582 |
sequestering of BMP in extracellular matrix(GO:0035582) |
| 0.3 |
0.5 |
GO:2000170 |
positive regulation of peptidyl-cysteine S-nitrosylation(GO:2000170) |
| 0.3 |
3.2 |
GO:1904321 |
response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.3 |
1.3 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.3 |
3.4 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.3 |
0.3 |
GO:2000277 |
positive regulation of oxidative phosphorylation uncoupler activity(GO:2000277) |
| 0.3 |
3.1 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 |
0.8 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
1.2 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.2 |
0.7 |
GO:1902219 |
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.2 |
3.7 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.2 |
2.7 |
GO:1904030 |
negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
| 0.2 |
1.9 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.2 |
2.4 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.2 |
1.6 |
GO:2000653 |
regulation of genetic imprinting(GO:2000653) |
| 0.2 |
2.4 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.2 |
0.7 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.2 |
0.7 |
GO:2000668 |
dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
| 0.2 |
3.5 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.2 |
1.9 |
GO:0035988 |
chondrocyte proliferation(GO:0035988) |
| 0.2 |
0.6 |
GO:0060478 |
acrosomal vesicle exocytosis(GO:0060478) |
| 0.2 |
3.4 |
GO:0045653 |
negative regulation of megakaryocyte differentiation(GO:0045653) |
| 0.2 |
0.8 |
GO:0051176 |
positive regulation of sulfur metabolic process(GO:0051176) |
| 0.2 |
3.7 |
GO:0090083 |
regulation of inclusion body assembly(GO:0090083) |
| 0.2 |
2.6 |
GO:0009437 |
carnitine metabolic process(GO:0009437) |
| 0.2 |
9.7 |
GO:1904893 |
negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.2 |
4.2 |
GO:0035335 |
peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.2 |
1.6 |
GO:1900121 |
negative regulation of receptor binding(GO:1900121) |
| 0.2 |
8.2 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.2 |
7.3 |
GO:0000038 |
very long-chain fatty acid metabolic process(GO:0000038) |
| 0.2 |
2.1 |
GO:0031998 |
regulation of fatty acid beta-oxidation(GO:0031998) |
| 0.2 |
3.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.2 |
0.6 |
GO:0014042 |
positive regulation of mitochondrial fusion(GO:0010636) positive regulation of neuron maturation(GO:0014042) |
| 0.2 |
3.0 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 |
2.3 |
GO:0002227 |
innate immune response in mucosa(GO:0002227) |
| 0.2 |
3.8 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.2 |
7.3 |
GO:0051310 |
metaphase plate congression(GO:0051310) |
| 0.2 |
0.9 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) |
| 0.2 |
1.2 |
GO:0061469 |
regulation of type B pancreatic cell proliferation(GO:0061469) |
| 0.2 |
0.7 |
GO:0045652 |
regulation of megakaryocyte differentiation(GO:0045652) |
| 0.2 |
2.5 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.2 |
2.9 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.2 |
2.9 |
GO:0043153 |
photoperiodism(GO:0009648) entrainment of circadian clock by photoperiod(GO:0043153) |
| 0.2 |
15.3 |
GO:0006342 |
chromatin silencing(GO:0006342) |
| 0.2 |
0.2 |
GO:1902512 |
positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
| 0.2 |
2.8 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.2 |
3.5 |
GO:0021799 |
cerebral cortex radially oriented cell migration(GO:0021799) |
| 0.2 |
0.9 |
GO:1901844 |
regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
| 0.2 |
0.3 |
GO:0007354 |
zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.1 |
2.9 |
GO:0048169 |
regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.1 |
9.0 |
GO:0002181 |
cytoplasmic translation(GO:0002181) |
| 0.1 |
3.6 |
GO:0035640 |
exploration behavior(GO:0035640) |
| 0.1 |
2.2 |
GO:0070286 |
axonemal dynein complex assembly(GO:0070286) |
| 0.1 |
1.9 |
GO:0035094 |
response to nicotine(GO:0035094) |
| 0.1 |
0.4 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.1 |
0.3 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
3.7 |
GO:0036075 |
endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
| 0.1 |
1.0 |
GO:0090166 |
Golgi disassembly(GO:0090166) |
| 0.1 |
2.0 |
GO:0022038 |
corpus callosum development(GO:0022038) |
| 0.1 |
0.9 |
GO:0010820 |
positive regulation of T cell chemotaxis(GO:0010820) |
| 0.1 |
0.5 |
GO:0021780 |
oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 |
1.4 |
GO:0061179 |
negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 |
0.7 |
GO:0035428 |
hexose transmembrane transport(GO:0035428) |
| 0.1 |
0.5 |
GO:0036089 |
cleavage furrow formation(GO:0036089) |
| 0.1 |
6.0 |
GO:0061077 |
chaperone-mediated protein folding(GO:0061077) |
| 0.1 |
2.9 |
GO:0016242 |
negative regulation of macroautophagy(GO:0016242) |
| 0.1 |
0.3 |
GO:0046398 |
UDP-glucuronate biosynthetic process(GO:0006065) UDP-glucuronate metabolic process(GO:0046398) |
| 0.1 |
4.7 |
GO:0001676 |
long-chain fatty acid metabolic process(GO:0001676) |
| 0.1 |
0.5 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
2.0 |
GO:0014047 |
glutamate secretion(GO:0014047) |
| 0.1 |
1.4 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 |
1.8 |
GO:0050850 |
positive regulation of calcium-mediated signaling(GO:0050850) |
| 0.1 |
1.7 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
4.2 |
GO:0010811 |
positive regulation of cell-substrate adhesion(GO:0010811) |
| 0.1 |
0.7 |
GO:0032695 |
negative regulation of interleukin-12 production(GO:0032695) |
| 0.1 |
9.3 |
GO:0008203 |
cholesterol metabolic process(GO:0008203) |
| 0.1 |
1.5 |
GO:0051043 |
regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.1 |
2.2 |
GO:0045026 |
plasma membrane fusion(GO:0045026) |
| 0.1 |
1.2 |
GO:0032007 |
negative regulation of TOR signaling(GO:0032007) |
| 0.1 |
2.7 |
GO:0000027 |
ribosomal large subunit assembly(GO:0000027) |
| 0.1 |
6.0 |
GO:0051592 |
response to calcium ion(GO:0051592) |
| 0.1 |
0.9 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
2.9 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.1 |
0.7 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.1 |
5.1 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.1 |
0.9 |
GO:1901409 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
| 0.1 |
1.5 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.3 |
GO:1903748 |
negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
| 0.1 |
2.8 |
GO:1900087 |
positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
| 0.1 |
0.5 |
GO:0007274 |
neuromuscular synaptic transmission(GO:0007274) |
| 0.1 |
1.6 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.1 |
2.6 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.1 |
0.6 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 |
0.5 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.1 |
0.2 |
GO:0048352 |
neural plate mediolateral regionalization(GO:0021998) mesoderm structural organization(GO:0048338) paraxial mesoderm structural organization(GO:0048352) |
| 0.1 |
0.3 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
2.1 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.1 |
3.0 |
GO:0051017 |
actin filament bundle assembly(GO:0051017) |
| 0.1 |
1.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.1 |
1.8 |
GO:0031146 |
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.1 |
1.9 |
GO:0030514 |
negative regulation of BMP signaling pathway(GO:0030514) |
| 0.1 |
0.7 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.4 |
GO:0006105 |
succinate metabolic process(GO:0006105) |
| 0.1 |
0.3 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
| 0.1 |
1.0 |
GO:0007520 |
myoblast fusion(GO:0007520) |
| 0.1 |
0.4 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 |
1.5 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 |
0.4 |
GO:1901029 |
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
| 0.1 |
1.7 |
GO:0032728 |
positive regulation of interferon-beta production(GO:0032728) |
| 0.1 |
4.3 |
GO:1903749 |
positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
| 0.1 |
1.2 |
GO:0043001 |
Golgi to plasma membrane protein transport(GO:0043001) |
| 0.1 |
0.4 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.1 |
1.5 |
GO:0015985 |
energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 |
1.5 |
GO:0031365 |
N-terminal protein amino acid modification(GO:0031365) |
| 0.1 |
0.8 |
GO:0009083 |
branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 |
0.6 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.0 |
1.3 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.3 |
GO:0071549 |
response to dexamethasone(GO:0071548) cellular response to dexamethasone stimulus(GO:0071549) |
| 0.0 |
0.3 |
GO:0044381 |
glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
| 0.0 |
0.1 |
GO:1902237 |
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.0 |
0.4 |
GO:0071578 |
zinc II ion transmembrane import(GO:0071578) |
| 0.0 |
0.3 |
GO:0048570 |
notochord morphogenesis(GO:0048570) |
| 0.0 |
0.2 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.0 |
0.3 |
GO:0050995 |
negative regulation of lipid catabolic process(GO:0050995) |
| 0.0 |
1.4 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.3 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.7 |
GO:0050873 |
brown fat cell differentiation(GO:0050873) |
| 0.0 |
0.3 |
GO:0045002 |
double-strand break repair via single-strand annealing(GO:0045002) |
| 0.0 |
3.4 |
GO:0043123 |
positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
| 0.0 |
1.9 |
GO:0055072 |
iron ion homeostasis(GO:0055072) |
| 0.0 |
1.0 |
GO:0015807 |
L-amino acid transport(GO:0015807) |
| 0.0 |
0.2 |
GO:0070966 |
nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 |
0.8 |
GO:0010107 |
potassium ion import(GO:0010107) |
| 0.0 |
0.8 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.3 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.0 |
0.3 |
GO:0097034 |
mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
| 0.0 |
0.3 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.0 |
1.4 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
2.4 |
GO:0007030 |
Golgi organization(GO:0007030) |
| 0.0 |
1.7 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
1.3 |
GO:0031338 |
regulation of vesicle fusion(GO:0031338) |
| 0.0 |
0.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
1.0 |
GO:0006493 |
protein O-linked glycosylation(GO:0006493) |
| 0.0 |
0.5 |
GO:0009142 |
nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.0 |
1.1 |
GO:0051289 |
protein homotetramerization(GO:0051289) |
| 0.0 |
1.6 |
GO:1903052 |
positive regulation of proteolysis involved in cellular protein catabolic process(GO:1903052) |
| 0.0 |
0.4 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
1.0 |
GO:0060113 |
inner ear receptor cell differentiation(GO:0060113) |
| 0.0 |
0.1 |
GO:0048251 |
elastic fiber assembly(GO:0048251) |
| 0.0 |
0.2 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.4 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.3 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.0 |
0.3 |
GO:0010324 |
membrane invagination(GO:0010324) |
| 0.0 |
0.1 |
GO:0007263 |
nitric oxide mediated signal transduction(GO:0007263) |
| 0.0 |
0.2 |
GO:0016973 |
poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.0 |
0.1 |
GO:0097576 |
autophagosome maturation(GO:0097352) vacuole fusion(GO:0097576) |
| 0.0 |
0.1 |
GO:0010388 |
protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
